Brief: Ampio Pharmaceuticals' CEO Mike Martino Issues Letter To Stockholders
02/06/2022 21:36
June 2 (Reuters) - Ampio Pharmaceuticals Inc AMPE.A :
* AMPIO PHARMACEUTICALS' CEO MIKE MARTINO ISSUES LETTER TO
STOCKHOLDERS
* AMPIO PHARMACEUTICALS INC - BELIEVE IT WOULD BE AN UNWISE
USE OF
INVESTOR FUNDS TO CONTINUE COVID-19 PROGRAM AT THIS TIME
Source text for Eikon: ID:nPnqd5P2a
Further company coverage: AMPE.A
Recent news on Ampio Pharmaceuticals
See all newsBrief: Ampio Announces Voluntary Delisting And SEC Deregistration
Brief: Ampio Provides Update On Results From Pre-IND Enabling Studies
Brief: Ampio Selects Ascendia Pharmaceuticals, Inc. To Provide CDMO Services To Support Clinical Development Of OA-201
Brief: Ampio Pharmaceuticals Announces Reverse Stock Split
Brief: Ampio Pharmaceuticals Inc - Holds Approximately $1.25 Million In A Deposit Account At Silicon Valley Bank